We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

SALT - Success of Active Versus Passive Lead Fixation of Atrial Pacing/Sensing Electrodes (SALT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00180570
Recruitment Status : Suspended
First Posted : September 16, 2005
Last Update Posted : March 11, 2015
Information provided by:
Guidant Corporation

Brief Summary:
Randomised Comparison with regards to complication rate and electrical measurements of atrial leads with different fixation mechnism

Condition or disease Intervention/treatment Phase
Bradycardia Device: FineLine II Sterox, FineLine II Sterox, FineLine II Sterox EZ Phase 4

Detailed Description:
This investigation will study and compare 3 types of electrically identical, commercially available FineLine II Sterox leads with different fixation mechanisms. This trial has been designed to primarily study the difference in repositioning rate between active and passive fixation (straight and J-shaped) leads, if any. It will also monitor and document the behavior of the study leads, with special reference to electrical parameters and handling. Normal measurements are taken at pre-dicharge, 1-month 3-month and 12-month follow-up

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 385 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Scandinavian Atrial Lead Trial
Study Start Date : January 1997
Estimated Study Completion Date : January 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sodium
U.S. FDA Resources

Primary Outcome Measures :
  1. The primary objective of this study is to compare repositioning rate due to threshold > 3.0 V @ 0.5 ms or P-wave < 0.8 mV between FineLine II Sterox 4480 and 4470, and between 4456 and 4470.

Secondary Outcome Measures :
  1. 1. Other complications (Safety). To compare other lead related complication rates such as perforation, lead fracture and failure to implant. 2. Electrical properties

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients selected for participation in this investigation should be candidates for permanent pacemaker implantation chosen from the investigator's general patient population without regard for race or sex. Furthermore, these patients should, in the physician's general opinion, benefit from permanent pacemaker implantation with one of the study leads. Patients should be geographically stable and available for routine follow-up visits throughout the duration of the study. Patients must also be able and willing to provide informed consent.

Exclusion Criteria:

  • Patients who previously went through heart surgery should be excluded from the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00180570

Sahlgrenska Sjukhuset i Göteborg Sweden,
Goteborg, Sweden
Sponsors and Collaborators
Guidant Corporation
Principal Investigator: charles kennergren Sahlgrenska Sjukhuset i Göteborg Sweden

ClinicalTrials.gov Identifier: NCT00180570     History of Changes
Other Study ID Numbers: SALT-2
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: March 11, 2015
Last Verified: September 2005

Additional relevant MeSH terms:
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes